Effect of Telmisartan on metabolic syndrome correlation factor of OLETF rats fed with high-fat diet
Yao Rui-dong
Abstract
Yao Rui-dong
Abstract
【Objective】 To investigate the effect of Telmisartan on metabolic syndrome correlation factor in OLETF rats fed with high-fat diet.【Methods】 According to OGTT 2 h and body weight,forty-eight OLETF rats were randomly divided into five groups: Telmisartan(group L),combination of Telmisartan and Metformin(group LM),Pioglitazone(group P),Metformin(group M) and high-fat diet(group O).Twelve LETO rats fed with normal diet served as normal control group(group NC).At forty-eight weeks,morbidity of diabetes,FFA,serum lipids and body weight were observed after twenty-two weeks treated drugs.【Results】 Compared with group O,T2DM was decreased but no statistical significance(P =0.085).T2DM in group LM was significantly lower than group O(P =0.035);Compared with group O,the FFA,TC,TG,LDL were markedly decreased(P =0.040,0.023,0.037 and 0.000,respectively).The body weight of group P was higher than that of rats in other groups(P 0.05).【Conclusion】 Combination of Telmisartan and Metformin can prevent the morbidity of diabetes of OLETF rats fed with high-fat diet and improve FFA,serum lipid disorders,and the body weight keep stable.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
【Objective】 To investigate the effect of Telmisartan on metabolic syndrome correlation factor in OLETF rats fed with high-fat diet.【Methods】 According to OGTT 2 h and body weight,forty-eight OLETF rats were randomly divided into five groups: Telmisartan(group L),combination of Telmisartan and Metformin(group LM),Pioglitazone(group P),Metformin(group M) and high-fat diet(group O).Twelve LETO rats fed with normal diet served as normal control group(group NC).At forty-eight weeks,morbidity of diabetes,FFA,serum lipids and body weight were observed after twenty-two weeks treated drugs.【Results】 Compared with group O,T2DM was decreased but no statistical significance(P =0.085).T2DM in group LM was significantly lower than group O(P =0.035);Compared with group O,the FFA,TC,TG,LDL were markedly decreased(P =0.040,0.023,0.037 and 0.000,respectively).The body weight of group P was higher than that of rats in other groups(P 0.05).【Conclusion】 Combination of Telmisartan and Metformin can prevent the morbidity of diabetes of OLETF rats fed with high-fat diet and improve FFA,serum lipid disorders,and the body weight keep stable.
Key concepts: Telmisartan, Internal medicine, Endocrinology, Metformin, Pioglitazone, Medicine, Metabolic syndrome, Body weight